| sIPV | Sabin strain–based inactivated poliovirus vaccine |
| IPV | Inactivated poliovirus vaccine |
| OPV | Oral poliovirus vaccine |
| DTaP | Diphtheria–tetanus–acellular pertussis vaccine |
| DT | Diphtheria–tetanus vaccine |
| Hib | Haemophilus influenzae type b vaccine |
| MMR | Measles–mumps–rubella vaccine |
| BCG | Bacille Calmette–Guérin vaccine |
| EV71 | Enterovirus 71 vaccine |
| VAPP | Vaccine-associated paralytic poliomyelitis |
| VDPV | Vaccine-derived poliovirus |
| AEFI | Adverse events following immunization |
| CNAEFIS | China National Adverse Events Following Immunization Surveillance System |
| WHO | World Health Organization |
| GPEI | Global Polio Eradication Initiative |
| RR | Relative risk |
| aRR | Adjusted rate ratio |
| CI | Confidence interval |
| NB | Negative binomial (regression) |
| NHC | National Health Commission of China |
| NMPA | National Medical Products Administration |
| CDC | Center for Disease Control and Prevention |